99% Savings - Buy Just @1 Rs X
Glytop 2.5 Tablet SR is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Diabetes Type 2. Secondary and off-label uses of Glytop 2.5 Tablet SR have also been mentioned below.
The optimal dosage of Glytop 2.5 Tablet SR is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Glytop 2.5 Tablet SR as well, which are listed below. Normally, these side effects of Glytop 2.5 Tablet SR are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Glytop 2.5 Tablet SR's effect during pregnancy is Severe and Severe while nursing. In addition, Glytop 2.5 Tablet SR's effects on the liver, heart and kidney are discussed below in the Glytop 2.5 Tablet SR related warnings section.
Glytop 2.5 Tablet SR is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Heart Disease, Kidney Disease are examples of such conditions. Other contraindications of Glytop 2.5 Tablet SR have been discussed in the sections ahead.
Drug interactions for Glytop 2.5 Tablet SR have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Glytop 2.5 Tablet SR, it is important to know that it is safe while driving, and is habit-forming.
Glytop 2.5 Tablet SR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glytop 2.5 Tablet SR safe for pregnant women?
Glytop can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Glytop 2.5 Tablet SR safe during breastfeeding?
Taking Glytop may lead to serious side effects if you are breastfeeding. Glytop should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Glytop 2.5 Tablet SR on the Kidneys?
Effects of Glytop on kidney can be severe. It is not safe to use it without doctor's advice.
What is the effect of Glytop 2.5 Tablet SR on the Liver?
Glytop may have severe effects on your liver, so do not take it without first consulting your doctor.
What is the effect of Glytop 2.5 Tablet SR on the Heart?
Glytop is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Glytop 2.5 Tablet SR unless your doctor advises you to do so -
Is this Glytop 2.5 Tablet SR habit forming or addictive?
Glytop 2.5 Tablet SR does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Glytop 2.5 Tablet SR as it does not make you drowsy.
Is it safe?
Yes, but consume Glytop 2.5 Tablet SR only on doctor's advice.
Is it able to treat mental disorders?
No, Glytop 2.5 Tablet SR is not used to treat mental disorders.
Interaction between Food and Glytop 2.5 Tablet SR
There is no information on the effects of taking Glytop 2.5 Tablet SR with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Glytop 2.5 Tablet SR
Taking Glytop 2.5 Tablet SR with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucotrol - glipizide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158